TET2 and systemic mastocytosis: In hematopoietic canine tumors, TET2 mutations have also been observed in canine mast cell tumors but in very low frequency (2.7%) (81), contrary the TET2 mutations rate in human systemic mastocytosis, which are observed in 40% of the cases (82).